back to

Back to video list

Strategies to enhance checkpoint inhibition

Speaker

Paul J. Bröckelmann

Session

Checkpoint Inhibition in Hodgkin Lymphoma – State of the art and future perspectives

Others Talks of this Session

Firstline therapy of classical Hodgkin Lymphoma – How can immunotherapy improve outcome?
The current role of PD-1 inhibition in the treatment of relapsed or refractory classical Hodgkin Lymphoma